Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV and MMR Vaccine Concomitant Inoculation Study
NCT05279248Phase 4Unknown
- Start
- Aug 2021
- Primary completion
- Dec 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of human papillomavirus 16/18 bivalent vaccine, measles, mumps, and rubella vaccine in human papillomavirus infection, measles, mumps, rubella. Status: unknown.
02
Drugs
human papillomavirus 16/18 bivalent vaccinemeasles, mumps, and rubella vaccine
03
Conditions
human papillomavirus infectionmeaslesmumpsrubella
Beyond the preview
Go deeper on NCT05279248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05279248.